Search results
Health Minister JP Nadda urged to bring 'thalassemia' into national spotlight
Investing.com· 6 days agoHealth Minister JP Nadda urged to bring 'thalassemia' into national spotlight
Study Elucidates Skin Signs of VEXAS Syndrome
Medscape· 6 days agoSkin manifestations are common in the vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome and present early in the disease course....
Chelsea Counsel Co. Raises Stock Position in Prime Medicine, Inc. (NYSE:PRME)
ETF DAILY NEWS· 4 days agoChelsea Counsel Co. raised its holdings in shares of Prime Medicine, Inc. (NYSE:PRME – Free Report) by 733.3% during the fourth quarter, HoldingsChannel.com reports. The firm owned 5,000 shares ...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
LiveScience· 7 days agoIn an extremely rare case, a patient who received a cell-based cancer treatment later developed a...
Analysts Set Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Price Target at $164.00
ETF DAILY NEWS· 2 days agoUBS Group upped their target price on shares of Sarepta Therapeutics from $164.00 to $167.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. Needham ...
They found new immune responses that explain how some people avoid the coronavirus
Hardwood Paroxysm· 17 hours agoA scientific team has discovered new immune responses that help explain the infection of some...
uniQure director Gut Robert sells $17.9k in shares By Investing.com
Investing.com· 2 days agoIn a recent transaction, uniQure N.V. (NASDAQ:QURE) Director Gut Robert has sold a number of company...
What Caused Patient's Heart Palpitations and Periodic Weakness?
MedPage Today· 1 day agoWhat caused a patient in their 60s to develop intermittent heart palpitations and periodic weakness?...
The real reason you get menopause brain fog – and what you can do about it
The Telegraph via Yahoo News· 2 days agoI am turning 40 and honestly – really – I feel fine about my ageing body. My husband and I will grow...
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks· 3 days agoFree Report) reported new positive data from the phase I/II/III RUBY study of its lead candidate, reni-cel, in 18 patients with sickle cell disease (SCD) and the phase I/II EdiTHAL study of ...